N
214870
vs
TDY
N
214870
TDY
Over the past 12 months, NewGLab Pharma Co Ltd has underperformed TDY, delivering a return of 0% compared to the TDY's +35% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
214870
TDY
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
N
Intrinsic Value
24 961.84
KRW
Undervaluation 72%
TDY
Intrinsic Value
417.89
USD
Overvaluation 38%
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd
KOSDAQ:214870
|
6 915
KRW
|
|||||
|
Teledyne Technologies Inc
NYSE:TDY
|
677.02
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
214870, TDY
214870, TDY
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
N
|
NewGLab Pharma Co Ltd
Revenue
|
|||||||||||
|
|
Teledyne Technologies Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
214870, TDY
214870, TDY
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
N
|
NewGLab Pharma Co Ltd
KOSDAQ:214870
|
|||||||||
|
|
Teledyne Technologies Inc
NYSE:TDY
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
NewGLab Pharma Co Ltd
2.2%
TDY
42.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd | ||||
|
|
Teledyne Technologies Inc | ||||
Operating Margin
NewGLab Pharma Co Ltd
-100.3%
TDY
18.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd | ||||
|
|
Teledyne Technologies Inc | ||||
Net Margin
NewGLab Pharma Co Ltd
-62.9%
TDY
14.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd | ||||
|
|
Teledyne Technologies Inc | ||||
FCF Margin
NewGLab Pharma Co Ltd
23.1%
TDY
17.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd | ||||
|
|
Teledyne Technologies Inc | ||||
ROE
NewGLab Pharma Co Ltd
22.4%
TDY
8.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd | ||||
|
|
Teledyne Technologies Inc | ||||
ROA
NewGLab Pharma Co Ltd
-16.7%
TDY
6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd | ||||
|
|
Teledyne Technologies Inc | ||||
ROIC
NewGLab Pharma Co Ltd
-34.4%
TDY
6.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd | ||||
|
|
Teledyne Technologies Inc | ||||
ROCE
NewGLab Pharma Co Ltd
30.9%
TDY
8.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd | ||||
|
|
Teledyne Technologies Inc | ||||
Solvency Comparison
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
214870, TDY
214870, TDY
Performance By Year
214870, TDY
214870, TDY
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 214870 to other stocks
6861
Keyence Corp
More expensive
vs NewGLab Pharma Co Ltd
KEYS
Keysight Technologies In...
More expensive
vs NewGLab Pharma Co Ltd
002415
Hangzhou Hikvision Digit...
More expensive
vs NewGLab Pharma Co Ltd
HEXA B
Hexagon AB
More expensive
vs NewGLab Pharma Co Ltd
Select Stock to Compare
| JP |
|
Keyence Corp
TSE:6861
|
|
| US |
|
Keysight Technologies Inc
NYSE:KEYS
|
|
| CN |
|
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
|
|
| US |
|
Teledyne Technologies Inc
NYSE:TDY
|
|
| SE |
|
Hexagon AB
STO:HEXA B
|
|
| CN |
|
Zhonghang Electronic Measuring Instruments Co Ltd
SZSE:300114
|
|
| UK |
|
Halma PLC
LSE:HLMA
|
|
| TW |
|
Chroma ATE Inc
TWSE:2360
|
|
| US |
|
Trimble Inc
NASDAQ:TRMB
|
|
| CN |
|
Universal Scientific Industrial Shanghai Co Ltd
SSE:601231
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
